Application

17936691 · IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

Filed 2022-09-29 · Abandoned The official file ↗ · Art unit 1643 · Examiner Stephen L Rawlings Typical · CPC C07K 16/1282 · Allergan, Inc. · Foley Hoag, LLP (w/AVR)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

8.7 mo

to disposition 15.2 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.